Substance Misuse To Psychiatric Disorders for Cannabis
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
With the recent availability of vortioxetine, and the surging phenomenon of cannabis misuses
amongst young abusers, it is a timely opportunity to conduct an early pharmacotherapy
intervention study to offer an evidence-based strategy aiming to stop individuals with
cannabis use disorders with depressive or anxiety symptoms, to develop into a more chronic
disabling dependence or co-morbid state.